HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 32 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $68,500 | +183.7% | 88,216 | +9.7% | 0.00% | – |
| Q4 2022 | $24,145 | +201.8% | 80,403 | +361.9% | 0.00% | – |
| Q3 2022 | $8,000 | -46.7% | 17,407 | -32.1% | 0.00% | – |
| Q2 2022 | $15,000 | -68.8% | 25,640 | -31.7% | 0.00% | – |
| Q1 2022 | $48,000 | +14.3% | 37,563 | +1.1% | 0.00% | – |
| Q4 2021 | $42,000 | -22.2% | 37,141 | +6.0% | 0.00% | – |
| Q3 2021 | $54,000 | -70.0% | 35,036 | -61.5% | 0.00% | – |
| Q2 2021 | $180,000 | – | 91,106 | +197956.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 46 | -99.3% | 0.00% | – |
| Q4 2020 | $14,000 | – | 6,362 | +11681.5% | 0.00% | – |
| Q3 2020 | $0 | – | 54 | -37.2% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 86 | -89.6% | 0.00% | – |
| Q1 2020 | $1,000 | -94.7% | 823 | -76.6% | 0.00% | – |
| Q4 2019 | $19,000 | – | 3,519 | +7231.2% | 0.00% | – |
| Q3 2019 | $0 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 923,230 | $2,022,000 | 0.82% |
| Worth Venture Partners, LLC | 233,947 | $512,000 | 0.40% |
| PERKINS CAPITAL MANAGEMENT INC | 150,000 | $329,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 89,067 | $195,000 | 0.03% |
| PREMIER ASSET MANAGEMENT LLC | 70,000 | $153,000 | 0.03% |
| Allen Capital Group, LLC | 23,685 | $52,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 50,000 | $110,000 | 0.01% |
| Prospera Financial Services Inc | 39,300 | $86,000 | 0.01% |
| Onex Canada Asset Management Inc. | 20,000 | $44,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 95,300 | $208,000 | 0.00% |